Changes related to "Cyclophosphamide (Cytoxan)"

Jump to: navigation, search

This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide minor edits | Show bots | Hide anonymous users | Hide registered users | Hide my edits

Show new changes starting from 18:52, 20 June 2018
   
Page name:

20 June 2018

     15:05  Breast cancer‎‎ (6 changes | history) . . (+3,855). . [Jwarner‎ (6×)]
 m    15:05 (cur | prev) . . (+17). . Jwarner (talk | contribs) (Variant #1, 20 mg/m2 weekly {{#subobject:96cac2|Variant=1}})
 m    11:01 (cur | prev) . . (-8). . Jwarner (talk | contribs) (Paclitaxel monotherapy, q3wk {{#subobject:3e5448|Regimen=1}})
 m    11:00 (cur | prev) . . (+1,748). . Jwarner (talk | contribs) (Gemcitabine & Bevacizumab {{#subobject:134dbe|Regimen=1}})
      10:56 (cur | prev) . . (+2,990). . Jwarner (talk | contribs) (Metastatic disease, maintenance after first-line therapy)
 m    10:52 (cur | prev) . . (+1,616). . Jwarner (talk | contribs) (Gemcitabine monotherapy {{#subobject:b240d6|Regimen=1}})
 m    10:49 (cur | prev) . . (-2,508). . Jwarner (talk | contribs) (GT (Taxol) {{#subobject:1285e|Regimen=1}})
 m   14:53  Diffuse large B-cell lymphoma‎‎ (3 changes | history) . . (+491). . [Jwarner‎ (3×)]
 m    14:53 (cur | prev) . . (+213). . Jwarner (talk | contribs)
 m    13:43 (cur | prev) . . (+2,393). . Jwarner (talk | contribs) (R-DHAP {{#subobject:18c266|Regimen=1}})
 m    13:37 (cur | prev) . . (-2,115). . Jwarner (talk | contribs) (ROAD {{#subobject:0d0c67|Regimen=1}})
 m   11:57  Mantle cell lymphoma‎ (diff | hist) . . (+105). . Jwarner (talk | contribs)
 m   11:53  Waldenström macroglobulinemia‎ (diff | hist) . . (+102). . Jwarner (talk | contribs)
 m   11:50  B-cell acute lymphoblastic leukemia‎ (diff | hist) . . (+32). . Jwarner (talk | contribs) (Chemoradiotherapy ("Course III"))
 m   11:45  Light-chain (AL) amyloidosis‎ (diff | hist) . . (+39). . Jwarner (talk | contribs) (Melphalan & Dexamethasone {{#subobject:c07166|Regimen=1}})
 m   11:33  CNS lymphoma‎ (diff | hist) . . (+49). . Jwarner (talk | contribs) (Upfront therapy, non-randomized or retrospective data)
 m   11:11  Multiple myeloma‎ (diff | hist) . . (+6). . Jwarner (talk | contribs)
 m   11:07  Prostate cancer‎ (diff | hist) . . (+34). . Jwarner (talk | contribs) (Ipilimumab & RT {{#subobject:33 |Regimen=1}})
 m   10:38  Follicular lymphoma‎ (diff | hist) . . (-3,669). . Jwarner (talk | contribs)

19 June 2018

 m   22:51  Waldenström macroglobulinemia‎ (diff | hist) . . (+43). . Jwarner (talk | contribs)
 m   22:49  Marginal zone lymphoma‎ (diff | hist) . . (+57). . Jwarner (talk | contribs) (Fludarabine & Rituximab {{#subobject:413f96|Regimen=1}})
 m   22:46  Follicular lymphoma‎‎ (2 changes | history) . . (+42). . [Jwarner‎ (2×)]
 m    22:46 (cur | prev) . . (-16). . Jwarner (talk | contribs)
 m    22:45 (cur | prev) . . (+58). . Jwarner (talk | contribs) (Advanced disease, first-line therapy, non-randomized or retrospective data)
 m   17:49  Chronic lymphocytic leukemia (CLL/SLL)‎ (diff | hist) . . (+11). . Jwarner (talk | contribs)
 m   17:36  HIV-associated lymphoma‎‎ (2 changes | history) . . (+195). . [Jwarner‎ (2×)]
 m    17:36 (cur | prev) . . (+2,688). . Jwarner (talk | contribs) (Upfront therapy)
 m    17:35 (cur | prev) . . (-2,493). . Jwarner (talk | contribs) (DR-COP {{#subobject:ec091e|Regimen=1}})
 m   17:24  Breast cancer‎ (diff | hist) . . (-260). . Jwarner (talk | contribs)
 m   17:05  CNS lymphoma‎ (diff | hist) . . (-171). . Jwarner (talk | contribs)
 m   11:28  Light-chain (AL) amyloidosis‎‎ (2 changes | history) . . (+93). . [Jwarner‎ (2×)]
 m    11:28 (cur | prev) . . (+2,644). . Jwarner (talk | contribs) (VMD {{#subobject:ce3e96|Regimen=1}})
 m    11:27 (cur | prev) . . (-2,551). . Jwarner (talk | contribs) (CyBorD {{#subobject:d1f835|Regimen=1}})
 m   11:26  Multiple myeloma‎ (diff | hist) . . (+1,082). . Jwarner (talk | contribs)

18 June 2018

     22:33  Small cell lung cancer‎‎ (3 changes | history) . . (+5,328). . [Jwarner‎ (3×)]
      22:33 (cur | prev) . . (+5,674). . Jwarner (talk | contribs) (Limited stage, consolidation)
 m    22:32 (cur | prev) . . (-437). . Jwarner (talk | contribs) (Limited stage, definitive chemoradiotherapy)
 m    22:16 (cur | prev) . . (+91). . Jwarner (talk | contribs) (Limited stage, induction)
 m   20:56  Hodgkin lymphoma‎‎ (2 changes | history) . . (+148). . [Jwarner‎ (2×)]
 m    20:56 (cur | prev) . . (+4). . Jwarner (talk | contribs) (Subsequent treatment)
 m    20:55 (cur | prev) . . (+144). . Jwarner (talk | contribs) (Consolidation after upfront therapy)
 m   20:48  Follicular lymphoma‎‎ (3 changes | history) . . (-2,875). . [Jwarner‎ (3×)]
 m    20:48 (cur | prev) . . (+431). . Jwarner (talk | contribs) (BVR {{#subobject:ad1aa9|Regimen=1}})
 m    20:43 (cur | prev) . . (-3,314). . Jwarner (talk | contribs) (VBR {{#subobject:bdecdf|Regimen=1}})
 m    17:48 (cur | prev) . . (+8). . Jwarner (talk | contribs)
 m   17:52  Waldenström macroglobulinemia‎ (diff | hist) . . (+81). . Jwarner (talk | contribs)
 m   17:42  Multiple myeloma‎‎ (5 changes | history) . . (-83). . [Jwarner‎ (5×)]
 m    17:42 (cur | prev) . . (-94). . Jwarner (talk | contribs)
 m    17:41 (cur | prev) . . (+3,384). . Jwarner (talk | contribs) (VT {{#subobject:e94510|Regimen=1}})
 m    17:37 (cur | prev) . . (-3,293). . Jwarner (talk | contribs) (Bortezomib & Prednisone {{#subobject:ee2988|Regimen=1}})
 m    17:13 (cur | prev) . . (+2,087). . Jwarner (talk | contribs) (PAD {{#subobject:955a56|Regimen=1}})
 m    16:58 (cur | prev) . . (-2,167). . Jwarner (talk | contribs) (BDD {{#subobject:6ab815|Regimen=1}})
 m   17:36  Light-chain (AL) amyloidosis‎ (diff | hist) . . (-1). . Jwarner (talk | contribs) (Bortezomib & Melphalan, then auto HSCT {{#subobject:5426f4|Regimen=1}})
 m   17:27  Chronic lymphocytic leukemia (CLL/SLL)‎‎ (5 changes | history) . . (-3,648). . [Jwarner‎ (5×)]
 m    17:27 (cur | prev) . . (+147). . Jwarner (talk | contribs) (BendOfa {{#subobject:4eab04|Regimen=1}})
 m    17:24 (cur | prev) . . (+2,297). . Jwarner (talk | contribs) (CFAR {{#subobject:30ac6b|Regimen=1}})
 m    17:23 (cur | prev) . . (-2,273). . Jwarner (talk | contribs) (G-B {{#subobject:e26569|Regimen=1}})
 m    11:38 (cur | prev) . . (+21). . Jwarner (talk | contribs) (Placebo)
 m    11:27 (cur | prev) . . (-3,840). . Jwarner (talk | contribs) (Lenalidomide monotherapy {{#subobject:9820ba|Regimen=1}})
 m   13:36  Hodgkin lymphoma, nodular lymphocyte-predominant‎ (diff | hist) . . (-175). . Jwarner (talk | contribs) (ABVD {{#subobject:4c2988|Regimen=1}})